Weekly 24-h infusion of high-dose 5-flurouracil and leucovorin in patients with advanced gastric cancer

Anti-Cancer Drugs

Volumn 10, Issue 4, 1999, Pages 355-359

  Chen, Jen Shi ^a   Liu, Hsueh Erh ^a   Wang, Cheng Hsu ^b   Yang, Tsai Shen ^a   Wang, Hung Ming ^b   Liau, Chi Ting ^a   Chang, Wen Cheng ^b   Lin, Yung Chang ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Gastric cancer; High dose 5 fluorouracil; Infusion pump; Leucovorin

Indexed keywords

ANTIDOTE; ANTINEOPLASTIC ANTIMETABOLITE; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG ADMINISTRATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; STOMACH TUMOR;

ADULT; AGED; ANTIDOTES; ANTIMETABOLITES, ANTINEOPLASTIC; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; LEUCOVORIN; MALE; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 0033111635     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199904000-00002     Document Type: Article

References (25)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. ÇA 1997; 47: 5-27.
2. Neugut AI, Hayek M, Howe G. Epidemiology of gastric cancer. Semin Oiicol 1996; 3: 281-91.
3. Bruckner HW, Stablein DM. Sites of treatment failure: gastrointestinal tumor study group analyses of gastric, pancreatic, and colorectal cancer. Treat Symp 1983; 2: 199.
4. Kennedy BJ. TNM classification of stomach cancer. Cancer 1970; 26: 971-83-
5. Taira K, Keiichi M, Mitsuru S, Kuzuo O. Treatment results of gastric cancer patients: Japanese experience. In: Nishi, M, Ichikawa, H, Nakajiomi, T and Tahara E, eds. Gastric cancer. Berlin: Springer-Verlag 1993: 319-30.
6. Wils J. The treatment of advanced gastric cancer. Scmin Oncot 1996; 23: 397-406.
7. Wils J, Klein HO, Wagener DJ, et al. Sequential high-dose methotrexate and fluorouracil combined with doxorubicin-a step ahead in the treatment of advanced gastric cancer, a trial of the European Organization for Research and Treatment of Cancer gastrointestinal tract cooperative group. JClin Oncol 1991; 9: 827-31-
8. Findlay M, Cunningham D. Chemotherapy of carcinoma of the stomach. Cancer Treat Rev 1993; 19: 29-44.
9. MacDonald JS, Schein PS, Woolley PV, et al. 5-Fluorouracil, doxorubicin and mitomycin-C (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med 1980; 93: 533-6.
10. Preusser P, Achterrath W, Wilke H, et al. Chemotherapy of gastric cancer. Cancer Treat Rev 1988; 15: 257-77.
11. Wilke H, Preusser P, Fink U, et al. High-dose folinic acid/ etoposide/5-fluorouracil in advanced gastric cancer-a phase II study in elderly patients or patients with cardiac risk. Invest New drugs 1990; 8: 65-70.
12. The Advance Colorectal Cancer Meta-Analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer evidence in terms of response rate./ Clin Oncol 1992; 6: 896-903.
13. Ardalan B, Chua L, Tian EM, et al. A phase II study of weekly 24-hour infusion with high-dose 5-fluorouracil with leucovorin in colorectal carcinoma. J Clin Oncol 1991; 9: 625-30.
14. Vanhoefer U, Wilke H, Weh HJ, et al. Weekly high-dose 5fluorouracil and folinic acid as salvage treatment in advanced gastric cancer. Ann Oncol 1994; 5: 850-1.
15. Hsu CH, Heh KH, Chen LT, et al. Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancers. Oncology 1997; 54: 275-80.
16. Berenberg JL, Tangen C, Macdonald JS, et al. Phase D study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer. A Southwest Oncology Group study. Cancer 1995; 76: 715-9.
17. Rubin J. Gallagher JG. Schroeder G, et al. Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma. Cancer 1996; 78: 188891.
18. Louvet C, de Gramont A, Demuynck B, et al. High-dose folinic acid, 5-fluorouracil bolus and continuous infusion in poor-prognosis patients with advanced measurable gastric cancer. Ann Oncol 1991; 2: 229-30.
19. Houghton JA, Williams LG, de Graaf SSN, et al. Relationship between dose rate of [6AS]leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-meththylenetetrahydrofolate and tetrahydrofolate in human colon adenocarcinoma xenograft. Cancer Res 1990; 50: 3493-2.
20. Houghton JA, Williams LG, Cheshire PJ, et al. Influence of dose of [öÄSJIeuconin on reduced folate pools and 5fluorouracil-mediated tlimidylated synthase inhibition in human colon adenocarcinoma xerograft. Cancer Res 1990; 50: 3940-6.
21. Boarman DM, Allegra CJ. Intracellular metabolism of 5formyl tetrahydrofolate in human breast and colon cell lines. Cancer Res 1992; 52: 36-44.
22. Jolivet J. Role of leucovorin dosing and administration schedule. EurJ Cancer 1995; 31A: 1311-5.
23. Liaw CC, Liaw SJ, Wang CH, Chiu MC, Huang JS. Transient hyperammonemia related to chemotherapy with continuous infusion of liigh-dose 5-fluorouracil. Anti-Cancer Drugs 1993; 4: 311-5.
24. Yeh KH, Cheng AL High-dose 5-fluorouracil infusion therapy is associated with hyperammonemia, lactic acidosis and encephalopathy. BrJMcd 1997; 75: 464-5.
25. Bokemeyer C, Lampe CS, Clemens MR et al. A phase II trial of paclitaxel and weekly 24 h infusion of 5fluorouracil/folinic acid in patients with advanced gastric cancer. Anti-Cancer Drugs 1997; 8: 396-9.